SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-09-254656
Filing Date
2009-12-17
Accepted
2009-12-17 12:30:02
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 425 18203
2 AMENDMENT NO. 3 TO AGREEMENT AND PLAN OF MERGER dex101.htm EX-10.1 13940
3 PRESS RELEASE dex991.htm EX-99.1 12951
4 GRAPHIC g35720g82v91.jpg GRAPHIC 10169
  Complete submission text file 0001193125-09-254656.txt   61206
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filed by) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-33093 | Film No.: 091246641
SIC: 2834 Pharmaceutical Preparations